{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:57:22Z","timestamp":1789059442541,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["13245"],"award-info":[{"award-number":["13245"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00423-019-01815-9","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:02:43Z","timestamp":1566792163000},"page":"681-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1007","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-6132","authenticated-orcid":false,"given":"Martin B.","family":"Niederle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Foeger-Samwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Riss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Selberherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Scheuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Niederle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kerschan-Schindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"issue":"1","key":"1815_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/jc.2007-0600","volume":"93","author":"H Siilin","year":"2008","unstructured":"Siilin H, Rastad J, Ljunggren O, Lundgren E (2008) Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity. J Clin Endocrinol Metab 93(1):47\u201353. \nhttps:\/\/doi.org\/10.1210\/jc.2007-0600","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1815_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1210\/jc.2017-01932","volume":"103","author":"NE Cusano","year":"2018","unstructured":"Cusano NE, Rubin MR, Silva BC, Tay YD, Williams JM, Agarwal S, Omeragic B, Guo XE, Bilezikian JP (2018) Skeletal microstructure and estimated bone strength improve following parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 103(1):196\u2013205. \nhttps:\/\/doi.org\/10.1210\/jc.2017-01932","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1815_CR3","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, Silverberg SJ (2015) Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and Densitometric presentation. J Clin Endocrinol Metab 100(9):3443\u20133451. \nhttps:\/\/doi.org\/10.1210\/jc.2015-2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1815_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12020-016-0931-8","volume":"55","author":"G Viccica","year":"2017","unstructured":"Viccica G, Cetani F, Vignali E, Miccoli M, Marcocci C (2017) Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 55(1):256\u2013265. \nhttps:\/\/doi.org\/10.1007\/s12020-016-0931-8","journal-title":"Endocrine"},{"key":"1815_CR5","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1210\/jc.2018-02483","volume":"104","author":"LJ Reid","year":"2019","unstructured":"Reid LJ, Muthukrishnan B, Patel D, Seckl JR, Gibb FW (2019) Predictors of nephrolithiasis, osteoporosis and mortality in primary hyperparathyroidism. J Clin Endocrinol Metab 104:3692\u20133700. \nhttps:\/\/doi.org\/10.1210\/jc.2018-02483","journal-title":"J Clin Endocrinol Metab"},{"issue":"7261","key":"1815_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","volume":"321","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. Bmj 321(7261):598\u2013602","journal-title":"Bmj"},{"issue":"3","key":"1815_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/eje.1.02225","volume":"155","author":"S De Geronimo","year":"2006","unstructured":"De Geronimo S, Romagnoli E, Diacinti D, D'Erasmo E, Minisola S (2006) The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol 155(3):415\u2013420. \nhttps:\/\/doi.org\/10.1530\/eje.1.02225","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1815_CR8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O'Fallon W, Riggs B (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14(10):1700\u20131707. \nhttps:\/\/doi.org\/10.1359\/jbmr.1999.14.10.1700","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1815_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-14-0343","volume":"171","author":"C Eller-Vainicher","year":"2014","unstructured":"Eller-Vainicher C, Battista C, Guarnieri V, Muscarella S, Palmieri S, Salcuni AS, Guglielmi G, Corbetta S, Minisola S, Spada A, Hendy GN, Cole DE, Chiodini I, Scillitani A (2014) Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism. Eur J Endocrinol 171(3):399\u2013406. \nhttps:\/\/doi.org\/10.1530\/EJE-14-0343","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1815_CR10","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99(10):3561\u20133569. \nhttps:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1815_CR11","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114\u20133121. \nhttps:\/\/doi.org\/10.1210\/jc.2007-0219","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1815_CR12","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415\u20135422. \nhttps:\/\/doi.org\/10.1210\/jc.2004-0028","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1815_CR13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/jbmr.3177","volume":"32","author":"K Lundstam","year":"2017","unstructured":"Lundstam K, Heck A, Godang K, Mollerup C, Baranowski M, Pernow Y, Aas T, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J, Group SS (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32(9):1907\u20131914. \nhttps:\/\/doi.org\/10.1002\/jbmr.3177","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1815_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/bjs.7044","volume":"97","author":"A Sitges-Serra","year":"2010","unstructured":"Sitges-Serra A, Garcia L, Prieto R, Pena MJ, Nogues X, Sancho JJ (2010) Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women. Br J Surg 97(7):1013\u20131019. \nhttps:\/\/doi.org\/10.1002\/bjs.7044","journal-title":"Br J Surg"},{"issue":"4","key":"1815_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jc.2014-3441","volume":"100","author":"K Lundstam","year":"2015","unstructured":"Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Varhaug JE, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J, Group SS (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100(4):1359\u20131367. \nhttps:\/\/doi.org\/10.1210\/jc.2014-3441","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1815_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.endinu.2018.05.010","volume":"66","author":"L Ramos","year":"2019","unstructured":"Ramos L, Piedra M, Munoz P, Vazquez LA, Garcia-Unzueta MT, Montalban C, Amado JA (2019) Bone mineral density evolution and incidence of fractures in a cohort of patients with primary hyperparathyroidism treated with parathyroid surgery vs active surveillance during 6 years of follow-up. Endocrinol Diabetes Nutr 66(1):41\u201348. \nhttps:\/\/doi.org\/10.1016\/j.endinu.2018.05.010","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"2 Suppl 1","key":"1815_CR17","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.bone.2005.07.029","volume":"38","author":"PJ Marie","year":"2006","unstructured":"Marie PJ (2006) Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 38(2 Suppl 1):S10\u2013S14","journal-title":"Bone"},{"key":"1815_CR18","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.bone.2007.02.003","volume":"40","author":"PJ Marie","year":"2007","unstructured":"Marie PJ (2007) Strontium ranelate: new insights into its dual mode of action. Bone 40:S5\u2013S8","journal-title":"Bone"},{"issue":"5","key":"1815_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350(5):459\u2013468","journal-title":"N Engl J Med"},{"issue":"5","key":"1815_CR20","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1210\/jc.2004-1774","volume":"90","author":"JY Reginster","year":"2005","unstructured":"Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90(5):2816\u20132822","journal-title":"J Clin Endocrinol Metab"},{"key":"1815_CR21","first-page":"CD005326","volume":"4","author":"S O'Donnell","year":"2006","unstructured":"O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY (2006) Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev 4:CD005326","journal-title":"Cochrane Database Syst Rev"},{"key":"1815_CR22","first-page":"1359","volume":"10","author":"E Seeman","year":"2007","unstructured":"Seeman E, Devogelaer JP, Lorenc RS, Spector T, Brixen K, Balogh A, Stucki G, Reginster JY (2007) Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res 10:1359","journal-title":"J Bone Miner Res"},{"issue":"2 Suppl 1","key":"1815_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2005.09.023","volume":"38","author":"P Ammann","year":"2006","unstructured":"Ammann P (2006) Strontium ranelate: a physiological approach for an improved bone quality. Bone 38(2 Suppl 1):15\u201318","journal-title":"Bone"},{"issue":"11","key":"1815_CR24","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O'Brien CA, Manolagas SC, Jilka RL (2005) Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146(11):4577\u20134583. \nhttps:\/\/doi.org\/10.1210\/en.2005-0239","journal-title":"Endocrinology"},{"issue":"9","key":"1815_CR25","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"Pascale Chavassieux","year":"2019","unstructured":"Chavassieux P, Chapurlat R, Portero-Muzy N, Roux JP, Garcia P, Brown JP, Libanati C, Boyce RW, Wang A, Grauer A (2019) Bone-forming and Antiresorptive effects of Romosozumab in postmenopausal women with osteoporosis: bone Histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Miner Res. \nhttps:\/\/doi.org\/10.1002\/jbmr.3735","journal-title":"Journal of Bone and Mineral Research"},{"issue":"8","key":"1815_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137\u20131141","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1815_CR27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.4158\/EP12166.RA","volume":"18","author":"JP Bilezikian","year":"2012","unstructured":"Bilezikian JP (2012) Primary hyperparathyroidism. Endocr Pract 18(5):781\u2013790. \nhttps:\/\/doi.org\/10.4158\/EP12166.RA","journal-title":"Endocr Pract"},{"issue":"10","key":"1815_CR28","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1210\/jc.2014-2000","volume":"99","author":"R Udelsman","year":"2014","unstructured":"Udelsman R, Akerstrom G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99(10):3595\u20133606. \nhttps:\/\/doi.org\/10.1210\/jc.2014-2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1815_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons Guidelines for definitive Management of Primary Hyperparathyroidism. JAMA Surg 151(10):959\u2013968. \nhttps:\/\/doi.org\/10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg"},{"issue":"2","key":"1815_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/jc.2012-3048","volume":"98","author":"JM Kaufman","year":"2013","unstructured":"Kaufman JM, Audran M, Bianchi G, Braga V, Diaz-Curiel M, Francis RM, Goemaere S, Josse R, Palacios S, Ringe JD, Felsenberg D, Boonen S (2013) Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab 98(2):592\u2013601. \nhttps:\/\/doi.org\/10.1210\/jc.2012-3048","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1815_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4248\/BR201302005","volume":"1","author":"JM Liu","year":"2013","unstructured":"Liu JM, Cusano NE, Silva BC, Zhao L, He XY, Tao B, Sun LH, Zhao HY, Fan WW, Romano ME, Ning G, Bilezikian JP (2013) Primary hyperparathyroidism: a tale of two cities revisited - New York and Shanghai. Bone Res 1(2):162\u2013169. \nhttps:\/\/doi.org\/10.4248\/BR201302005","journal-title":"Bone Res"},{"issue":"2","key":"1815_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-13-0305","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Verga U, Scillitani A, Beck-Peccoz P, Chiodini I (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169(2):155\u2013162. \nhttps:\/\/doi.org\/10.1530\/EJE-13-0305","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1815_CR33","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.surg.2012.08.015","volume":"152","author":"BM Dy","year":"2012","unstructured":"Dy BM, Grant CS, Wermers RA, Kearns AE, Huebner M, Harmsen WS, Thompson GB, Farley DR, Richards ML (2012) Changes in bone mineral density after surgical intervention for primary hyperparathyroidism. Surgery 152(6):1051\u20131058. \nhttps:\/\/doi.org\/10.1016\/j.surg.2012.08.015","journal-title":"Surgery"},{"issue":"17\u201318","key":"1815_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10354-012-0125-9","volume":"163","author":"K Kerschan-Schindl","year":"2013","unstructured":"Kerschan-Schindl K (2013) Bone turnover in hyperparathyroidism. Wien Med Wochenschr 163(17\u201318):391\u2013396. \nhttps:\/\/doi.org\/10.1007\/s10354-012-0125-9","journal-title":"Wien Med Wochenschr"},{"issue":"6","key":"1815_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1055\/s-0032-1308998","volume":"44","author":"K Kerschan-Schindl","year":"2012","unstructured":"Kerschan-Schindl K, Riss P, Krestan C, Rauner M, Bieglmayer C, Gleiss A, Fialka-Moser V, Niederle B, Pietschmann P (2012) Bone metabolism in patients with primary hyperparathyroidism before and after surgery. Horm Metab Res 44(6):476\u2013481. \nhttps:\/\/doi.org\/10.1055\/s-0032-1308998","journal-title":"Horm Metab Res"},{"issue":"11","key":"1815_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/M15-1232","volume":"164","author":"MW Yeh","year":"2016","unstructured":"Yeh MW, Zhou H, Adams AL, Ituarte PH, Li N, Liu IL, Haigh PI (2016) The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann Intern Med 164(11):715\u2013723. \nhttps:\/\/doi.org\/10.7326\/M15-1232","journal-title":"Ann Intern Med"},{"key":"1815_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bone.2019.01.029","volume":"121","author":"GO Pires","year":"2019","unstructured":"Pires GO, Vieira IO, Hernandes FR, Teixeira AL, Oliveira IB, Dominguez WV, Dos Reis LM, Montenegro FM, Moyses RM, Carvalho AB, Jorgetti V (2019) Effects of parathyroidectomy on the biology of bone tissue in patients with chronic kidney disease and secondary hyperparathyroidism. Bone 121:277\u2013283. \nhttps:\/\/doi.org\/10.1016\/j.bone.2019.01.029","journal-title":"Bone"},{"issue":"5","key":"1815_CR38","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen S, Hauge EM, Rasmussen L, Jensen JE, Brixen K (2012) Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 27(5):1150\u20131158. \nhttps:\/\/doi.org\/10.1002\/jbmr.1540","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1815_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00423-012-1026-5","volume":"398","author":"L Rolighed","year":"2013","unstructured":"Rolighed L, Vestergaard P, Heickendorff L, Sikjaer T, Rejnmark L, Mosekilde L, Christiansen P (2013) BMD improvements after operation for primary hyperparathyroidism. Langenbeck's Arch Surg 398(1):113\u2013120. \nhttps:\/\/doi.org\/10.1007\/s00423-012-1026-5","journal-title":"Langenbeck's Arch Surg"},{"issue":"1","key":"1815_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-17-0416","volume":"178","author":"RM Kaderli","year":"2018","unstructured":"Kaderli RM, Riss P, Dunkler D, Pietschmann P, Selberherr A, Scheuba C, Niederle B (2018) The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism. Eur J Endocrinol 178(1):1\u20139. \nhttps:\/\/doi.org\/10.1530\/EJE-17-0416","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1815_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jocd.2007.01.002","volume":"10","author":"GM Blake","year":"2007","unstructured":"Blake GM, Lewiecki EM, Kendler DL, Fogelman I (2007) A review of strontium ranelate and its effect on DXA scans. J Clin Densitom 10(2):113\u2013119. \nhttps:\/\/doi.org\/10.1016\/j.jocd.2007.01.002","journal-title":"J Clin Densitom"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-019-01815-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-019-01815-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-019-01815-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T23:11:08Z","timestamp":1598310668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-019-01815-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1815"],"URL":"https:\/\/doi.org\/10.1007\/s00423-019-01815-9","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study procedures of this double-blind, placebo-controlled, randomized trial were approved by the Ethics Committee of the Medical University of Vienna (EKNr: 2142008), the Austrian Agency for Health and Food Safety (\u00d6sterreichische Agentur f\u00fcr Gesundheit und Ern\u00e4hrungssicherheit),  (identifier: NCT01222026), and European Union Drug Regulating Authorities Clinical Trials. All study participants gave written informed consent in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PP has received research support and\/or honoraria from Amgen GmbH, Biomedica GmbH, DePuySynthes, Fresenius Kabi Austria, Meda Pharma\/Mylan GmbH, Shire Austria GmbH, TAmiRNA GmbH, and UCB Pharma. All authors have declared that no competing financial interests or other conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}